tiprankstipranks
Trending News
More News >
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
US Market

Integra Lifesciences (IART) Financial Statements

Compare
257 Followers

Integra Lifesciences Financial Overview

Integra Lifesciences's market cap is currently $770.80M. The company's EPS TTM is $0.83; its P/E ratio is -1.85; Integra Lifesciences is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.64B$ 1.61B$ 1.54B$ 1.56B$ 1.54B
Gross Profit$ 845.23M$ 882.06M$ 884.74M$ 970.31M$ 944.64M
Operating Income$ 68.32M$ 28.41M$ 111.53M$ 238.92M$ 197.23M
EBITDA$ -326.20M$ 193.29M$ 255.96M$ 384.60M$ 366.33M
Net Income$ -516.47M$ -6.94M$ 67.74M$ 180.55M$ 169.07M
Balance Sheet
Cash & Short-Term Investments$ 263.74M$ 273.57M$ 309.10M$ 456.66M$ 513.45M
Total Assets$ 3.60B$ 4.04B$ 3.78B$ 3.89B$ 3.78B
Total Debt$ 215.83M$ 1.98B$ 1.68B$ 1.63B$ 1.67B
Net Debt$ -19.22M$ 1.74B$ 1.41B$ 1.17B$ 1.15B
Total Liabilities$ 2.56B$ 2.49B$ 2.19B$ 2.09B$ 2.10B
Stockholders' Equity$ 1.04B$ 1.55B$ 1.59B$ 1.80B$ 1.68B
Cash Flow
Free Cash Flow$ -31.05M$ 24.96M$ 73.09M$ 217.38M$ 264.35M
Operating Cash Flow$ 50.38M$ 129.38M$ 139.96M$ 264.47M$ 312.43M
Investing Cash Flow$ -108.06M$ -390.81M$ -94.18M$ -58.58M$ -161.44M
Financing Cash Flow$ 28.34M$ 237.86M$ -229.93M$ -251.95M$ -98.23M
Currency in USD

Integra Lifesciences Earnings and Revenue History

Integra Lifesciences Debt to Assets

Integra Lifesciences Cash Flow

Integra Lifesciences Forecast EPS vs Actual EPS